Baxter International (BAX) Capital Expenditures (2009 - 2026)

Baxter International (BAX) has 18 years of Capital Expenditures data on file, last reported at $137.0 million in Q1 2026.

• On a quarterly basis, Capital Expenditures rose 12.3% year-over-year to $137.0 million in Q1 2026; TTM through Mar 2026 was $528.0 million, a 15.28% increase from a year earlier, with the FY2025 full-year figure at $513.0 million, up 15.02% from the prior year.
• Capital Expenditures for Q1 2026 stood at $137.0 million, down from $140.0 million in the prior quarter.
• Over the last five years, Capital Expenditures for BAX reached as high as $165.0 million in Q1 2023 and fell as low as -$61.0 million in Q4 2022.
• Historically, Capital Expenditures has averaged $112.1 million across 5 years, with a median of $134.0 million in 2024.
• Across the five-year window, Capital Expenditures plunged 133.33% in 2022 and jumped 1016.67% in 2024, its largest moves.
• Year by year, Capital Expenditures stood at -$61.0 million in 2022, then soared by 250.82% to $92.0 million in 2023, then surged by 43.48% to $132.0 million in 2024, then increased by 6.06% to $140.0 million in 2025, then retreated by 2.14% to $137.0 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $137.0 million in Q1 2026, $140.0 million in Q4 2025, and $111.0 million in Q3 2025.